Search

News December 2018
... labor was about 6% at the 6-month interval, compared to 3.4% at the 18-month interval. Although the causes of poor ...
Council on Health Promotion / BY: Kara Solmundson, MD, CCFP (SEM), Sport Med Dip, MSc April 2018
... Canadians attain guideline levels of physical activity,[ 4 ] and only 15.8% of Canadian physicians provide patients ...
Clinical Articles / BY: Fahra Rajabali, MSc September 2018
... that everyone should live a long life in full health.[ 4 , 5 ] Disability-adjusted life years are calculated as the ... describing the total health loss at the population level.[ 4 ] The disability-adjusted life year permits comparisons ... 5 ] human capital, societal perspective approach.[ 4 , 6 ] The total economic impact of injury was assessed by ...
Letters / BY: Alexandra Choi, MD, MHSc, CCFP January/February 2018
... programs. Within Canada, Quebec has already adopted HiAP.[ 4 ] Farther from home, Scandinavian countries have seen ...
Clinical Articles / BY: Daniel Shearer, BSc June 2018
... be achieved safely without undue risk of hypoglycemia.[ 4 ] Above 7.0%, adverse outcomes increase by approximately ... ]  The safety of newer OHAs such as dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-glucose linked transporter 2 (SGLT2) ...
Obituaries / BY: William G. Johnston, MB, FRCS July/August 2018
... gave birth to her second son, Edward. Katie then took a 4-year leave from her medical practice to get her young ...
Clinical Articles / BY: Keith G. Dawson, MD, PhD, FRCPC November 2018
... as the most significant social determinant of health.[ 3 , 4 ] Other social determinants affecting diabetes in First ... in Canada, offering only restricted coverage for two DPP-4 agents, and no coverage for GLP-1s. BC is also the only ...
Letters / BY: David Kendler, MD March 2018
... 34.6% of patients on placebo. Infections occurred in 54.4% of placebo patients and 52.9% of denosumab-treated ... Serious adverse events of infections were reported in 3.4% of placebo subjects and 4.1% of denosumab subjects ( P  = 0.14). The references ...
Letters / BY: Romayne Gallagher, MD, CCFP(PC), FCFP September 2018
... prescription opioid deaths in BC from 2009 to 2013,[ 4 ] found that methadone, used as opioid agonist therapy, ...
Clinical Articles / BY: Robert C. Mack, MD July/August 2018
... then quantified at 10 residential care facilities over a 4-week period in 2016: Multi-dose packaging. Medications at ... who quantified the number of medications returned during a 4-week period. Remedy’sRx did not identify individual ... assigned numbers to anonymize the data. During the 4-week study period, medication changes came in over the ...